Drugs / SCB0020160
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07682337 | Jun 2026 → Jun 2027 expected | cancer, idiopathic pulmonary fibrosis, obesity disorder | SCBIO Inc. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SCB0020160 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07682337 ↗ |
| Route | Oral | “single and multiple oral doses of SCB0020160 administered under fasting conditions” NCT07682337 ↗ |